National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials and Insurance Coverage - A Resource Guide
    Posted: 12/30/1999    Updated: 01/30/2002



Clinical Trials and Insurance Coverage






Basics






Strategies






Initiatives



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
Basics

What costs do trials involve, and who is usually responsible for them?
What criteria do health plans use to make decisions about coverage for trials?
Medicare coverage

What costs do trials involve, and who is usually responsible for paying them?

There are two types of costs associated with a clinical trial: patient care costs and research costs.

Patient care costs fall into two categories:

  • Usual care costs, such as doctor visits, hospital stays, clinical laboratory tests, x-rays, etc., which occur whether you are participating in a trial or receiving standard treatment. These costs have usually been covered by a third-party health plan, such as Medicare or private insurance.

  • Extra care costs associated with clinical trial participation, such as the additional tests that may or may not be fully covered by the clinical trial sponsor and/or research institution. The sponsor and the participant's health plan need to resolve coverage of these costs for particular trials.

Research costs are those associated with conducting the trial, such as data collection and management, research physician and nurse time, analysis of results, and tests purely performed for research purposes. Such costs are usually covered by the sponsoring organization, such as the National Cancer Institute (NCI) or a pharmaceutical company.

Back to TopBack to Top

What criteria do health plans use to make decisions about reimbursement for trials?

Health insurance companies and managed care companies decide which health care services they will pay for by developing a coverage policy regarding the specific services. In general, the most important factor determining whether something is covered is a health plan's judgment as to whether the service is established or investigational. Health plans usually designate a service as established if there is a certain amount of scientific data to show that it is safe and effective. If the health plan does not think that such data exist in sufficient quantity, the plan may label the service as investigational.

Health care services delivered within the setting of a clinical trial are very often categorized as investigational and not covered. This is because the health plan thinks that the major reason to perform the clinical trial is that there is not enough data to establish the safety and effectiveness of the service being studied. Thus, for some health plans, any mention of the fact that the patient is involved in a clinical trial results in a denial of payment.

Your health plan may define specific criteria that a trial must meet before extending coverage, such as:

  • Sponsorship:
    Some plans may only cover costs of trials sponsored by organizations whose review and oversight of the trial is careful and scientifically rigorous, according to standards set by the health plan.

  • Trial phase and type:
    Some plans may cover patient care costs only for the clinical trials they judge to be "medically necessary" on a case-by-case basis. Trial phase may also affect coverage; for example, while a plan may be willing to cover costs associated with phase III trials, which include treatments that have already been successful with a certain number of people, the plan may require some documentation of effectiveness before covering a phase I or phase II trial.

    • While health plans are interested in efforts to improve prevention and screening, they currently seem less likely to have a review process in place for these trials. Therefore, it may be more difficult to get coverage for the care costs associated with them.

    • See What is a Clinical Trial? for a description of the phases of cancer clinical trials.

Some plans, especially smaller ones, will not cover any costs associated with a clinical trial. Policies vary widely, but in most cases your best bet is to have your doctor start discussions with the health plan.

  • Cost "neutrality":
    Some health plans may limit coverage to trials they consider cost-neutral (i.e., not significantly more expensive than the treatments considered standard).

  • Lack of standard therapy:
    Some plans limit coverage of trials to situations in which no standard therapy is available.

  • Facility and personnel qualifications:
    A health plan may require that the facility and medical staff meet specific qualifications to conduct a trial involving unique services, especially intensive therapy such as high-dose chemotherapy with bone marrow or stem cell transplantation.

Back to TopBack to Top

Medicare Coverage

For up-to-date information about Medicare coverage of clinical trials, go to the Web site for the Centers for Medicaid & Medicare (formerly the Health Care Financing Administration). As of January 2001, the following information was accurate:

If I'm in a clinical trial, what will Medicare pay?

  • Anything normally covered is still covered when it is part of a clinical trial. This includes test, procedures, and doctor visits that are ordinarily covered.

  • Anything normally covered even if it is a service or item associated with the experimental treatment. For example, Medicare will pay for the intravenous administration of a new chemotherapy drug being tested in a trial, including any therapy to prevent side effects from the new drug.

  • Anything normally covered even if it resulted from your being in the clinical trial. For example, a test or hospitalization resulting from a side effect of the new treatment that Medicare would ordinarily cover.

What costs are not covered?

  • Investigational items or services being tested in a trial. Sponsors of clinical trials often provide the new drug free, but make sure you ask your doctor before you begin.

  • Items or services used solely for the data collection needs of the trial.

  • Anything being provided free by the sponsor of the trial.

What kinds of clinical trials are covered?

The National Cancer Institute's Cancer Information Service has provided a fact sheet for Medicare beneficiaries (see More Choices in Cancer Care: Information for Beneficiaries on Medicare Coverage of Cancer Clinical Trials). In general, cancer treatment and diagnosis trials are covered if:

  • They are funded by the National Cancer Institute (NCI), NCI-Designated Cancer Centers, NCI-Sponsored Clinical Trials Cooperative Groups and all other federal agencies that fund cancer research. Other trials may be eligible for coverage and doctors can ask Medicare to pay the patients' costs. Ask your doctor about this before you begin.

  • They are designed to treat or diagnose your cancer.

  • The purpose or subject of the trial is within a Medicare benefit category. For example, cancer diagnosis and treatment are Medicare benefits, so these trials are covered. Cancer prevention trials are not currently covered.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov